IL94777A - חומצה ציס-)-( -h-1)]-4)2(-טטראזול-5-איל( מתיל(-2-פיפרידינקרבוקסילית, מלחים שלה, תהליך להכנתם ותכשירי רוקחות אנטגוניסטי - Google Patents

חומצה ציס-)-( -h-1)]-4)2(-טטראזול-5-איל( מתיל(-2-פיפרידינקרבוקסילית, מלחים שלה, תהליך להכנתם ותכשירי רוקחות אנטגוניסטי

Info

Publication number
IL94777A
IL94777A IL9477790A IL9477790A IL94777A IL 94777 A IL94777 A IL 94777A IL 9477790 A IL9477790 A IL 9477790A IL 9477790 A IL9477790 A IL 9477790A IL 94777 A IL94777 A IL 94777A
Authority
IL
Israel
Prior art keywords
cis
compound
methyl
amino acid
mixture
Prior art date
Application number
IL9477790A
Other languages
English (en)
Other versions
IL94777A0 (en
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of IL94777A0 publication Critical patent/IL94777A0/xx
Publication of IL94777A publication Critical patent/IL94777A/he

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
IL9477790A 1989-06-26 1990-06-18 חומצה ציס-)-( -h-1)]-4)2(-טטראזול-5-איל( מתיל(-2-פיפרידינקרבוקסילית, מלחים שלה, תהליך להכנתם ותכשירי רוקחות אנטגוניסטי IL94777A (he)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/371,568 US4968678A (en) 1988-02-19 1989-06-26 Tetrazole excitatory amino acid receptor antagonists

Publications (2)

Publication Number Publication Date
IL94777A0 IL94777A0 (en) 1991-04-15
IL94777A true IL94777A (he) 1994-05-30

Family

ID=23464503

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9477790A IL94777A (he) 1989-06-26 1990-06-18 חומצה ציס-)-( -h-1)]-4)2(-טטראזול-5-איל( מתיל(-2-פיפרידינקרבוקסילית, מלחים שלה, תהליך להכנתם ותכשירי רוקחות אנטגוניסטי

Country Status (17)

Country Link
US (1) US4968678A (he)
EP (1) EP0405834A3 (he)
JP (1) JPH0348679A (he)
KR (1) KR910000703A (he)
CN (1) CN1028024C (he)
AU (1) AU621498B2 (he)
CA (1) CA2019167A1 (he)
FI (1) FI903183A0 (he)
HU (1) HU206339B (he)
IE (1) IE902288A1 (he)
IL (1) IL94777A (he)
MX (1) MX21219A (he)
NZ (1) NZ234109A (he)
PH (1) PH26905A (he)
PT (1) PT94447B (he)
RU (2) RU1833385C (he)
ZA (1) ZA904717B (he)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0330353B1 (en) * 1988-02-19 1993-04-07 Eli Lilly And Company Tetrazole excitatory amino acid receptor antagonists
US5594007A (en) * 1991-04-18 1997-01-14 Pfizer Inc. Method for treating spinal cord trauma with phenolic 2-piperidino-1-alkanols
US5196421A (en) * 1991-06-05 1993-03-23 Eli Lilly And Company Excitatory amino acid receptor antagonists in methods for the use thereof
US5153196A (en) * 1991-06-05 1992-10-06 Eli Lilly And Company Excitatory amino acid receptor antagonists and methods for the use thereof
JPH07505648A (ja) * 1992-04-15 1995-06-22 メルク シヤープ エンド ドーム リミテツド アザサイクリック化合物
US5192751A (en) * 1992-07-24 1993-03-09 Eli Lilly And Company Use of competitive NMDA receptor antagonists in the treatment of urinary incontinence
US20040208875A1 (en) 1995-03-15 2004-10-21 Queen's University At Kingston Method for treating amyloidosis
ATE311864T1 (de) * 1993-03-29 2005-12-15 Propan-1,3-disulphonsäure und deren pharmazeutisch akzeptable salze zur behandlung von amyloidosis
ATE183184T1 (de) * 1994-01-31 1999-08-15 Pfizer Neuroprotektive chroman verbindungen
NZ284852A (en) * 1994-08-18 1998-06-26 Pfizer 3-(piperidin-1-yl)-chroman-4,7-diol and 1-(4-hydrophenyl)-2-(piperidin-1-yl) alkanol derivatives; medicaments; used as a neuroprotective agent
US5880138A (en) * 1996-10-01 1999-03-09 Eli Lilly And Company NMDA receptor selective antagonists
JP2006501957A (ja) * 2002-10-04 2006-01-19 クック ウロロジカル インコーポレイテッド ワイヤバスケットを備えた硬性摘出器具
US8043303B2 (en) * 2002-10-04 2011-10-25 Cook Medical Technologies Llc Handle for interchangeable medical device
US20070010573A1 (en) 2003-06-23 2007-01-11 Xianqi Kong Methods and compositions for treating amyloid-related diseases
US7244764B2 (en) 2003-06-23 2007-07-17 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
US7414076B2 (en) 2003-06-23 2008-08-19 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
WO2005084564A1 (en) * 2004-02-27 2005-09-15 Cook Urological Incorporated Self-tensioning handle for endoscopic device
CN101128421A (zh) 2004-12-22 2008-02-20 神经化学(国际)有限公司 治疗淀粉样相关疾病用的方法与组合物
TW200716088A (en) 2005-04-15 2007-05-01 Neurochem Int Ltd Formulations and methods for treating amyloidosis
US8597303B2 (en) * 2005-11-03 2013-12-03 Cook Medical Technologies Llc Articulating basket with simultaneous basket extension or basket retraction
US8372886B2 (en) 2005-12-22 2013-02-12 Kiacta Sarl Treatment of renal disorders, diabetic nephropathy and dyslipidemias
PL3851447T3 (pl) 2006-10-12 2024-03-04 Bellus Health Inc. Sposoby, związki, kompozycje i nośniki dostarczające kwas 3-amino-1-propanosulfonowy
EP3427729A1 (en) 2017-07-13 2019-01-16 Paris Sciences et Lettres - Quartier Latin Probenecid for use in treating epileptic diseases, disorders or conditions

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3536715A (en) * 1967-03-24 1970-10-27 Miles Lab 2-lower alkyl-5-(omega-(4-phenyl-1-piperazinyl) lower alkyl)-2h-tetrazoles
CA1248531A (en) * 1984-04-17 1989-01-10 Jeffrey C. Watkins 4-substituted piperazine-2-carboxylic acids
PH23848A (en) * 1985-05-24 1989-11-23 Ciba Geigy Ag Certain phosphonic acids and derivatives
US4746653A (en) * 1986-02-28 1988-05-24 Ciba-Geigy Corporation Certain hetero phosphonic acid derivatives of 2-piperidine or 2-tetrahydropyridinecarboxylates and esters thereof which are useful for the treatment of disorders responsive to blockade of the NMDA receptor in mammals
ES2031927T3 (es) * 1986-11-21 1993-01-01 Ciba-Geigy Ag Procedimiento para la obtencion de acidos fosfonicos insaturados y derivados.
EP0330353B1 (en) * 1988-02-19 1993-04-07 Eli Lilly And Company Tetrazole excitatory amino acid receptor antagonists

Also Published As

Publication number Publication date
FI903183A0 (fi) 1990-06-25
IE902288L (en) 1990-12-26
RU1833385C (ru) 1993-08-07
ZA904717B (en) 1992-02-26
IE902288A1 (en) 1991-01-16
MX21219A (es) 1993-11-01
HU206339B (en) 1992-10-28
US4968678A (en) 1990-11-06
PT94447B (pt) 1997-02-28
CA2019167A1 (en) 1990-12-26
IL94777A0 (en) 1991-04-15
HU903976D0 (en) 1990-11-28
EP0405834A3 (en) 1991-12-27
RU2089546C1 (ru) 1997-09-10
KR910000703A (ko) 1991-01-30
NZ234109A (en) 1992-04-28
PT94447A (pt) 1991-02-08
CN1048385A (zh) 1991-01-09
AU621498B2 (en) 1992-03-12
EP0405834A2 (en) 1991-01-02
CN1028024C (zh) 1995-03-29
PH26905A (en) 1992-12-03
JPH0348679A (ja) 1991-03-01
HUT54364A (en) 1991-02-28
AU5780890A (en) 1991-01-03

Similar Documents

Publication Publication Date Title
IL94777A (he) חומצה ציס-)-( -h-1)]-4)2(-טטראזול-5-איל( מתיל(-2-פיפרידינקרבוקסילית, מלחים שלה, תהליך להכנתם ותכשירי רוקחות אנטגוניסטי
JPH0637443B2 (ja) 1−フェニル−3−ナフタレニルオキシプロパンアミン類
US5250571A (en) (S)-norfluoxetine in method of inhibiting serotonin uptake
CA2002483C (en) Fluoxetine analog
US6303627B1 (en) Inhibitors of serotonin reuptake
AU608692B2 (en) Tetrazole excitatory amino acid receptor antagonists
US5389687A (en) Ring-substituted 2-amino-1,2,3,4-tetra-hydronaphthalenes
US5773463A (en) Indane and tetrahydronaphthalene derivatives as calcium channel antagonists
EP1208087B1 (en) Diester prodrugs of a decahydroisoquinoline-3-carboxylic acid
US5863952A (en) Enantiomers of 1-(3,4-dichlorobenzyl)-2-methylaminoindane
JPH02235A (ja) セロトニンおよびノルエピネフリン摂取阻害剤
US4902687A (en) Excitatory amino acid receptor antagonists
US5250572A (en) (R)-norfluoxetine in method for occupying serotonin IC receptors
US4876282A (en) 1-Phenylalkylamines as selective serotonin uptake inhibitors
SI9300217A (sl) Farmacevtiki, ki vsebujejo ariloksialkilamino in ariltioalkilamino derivate
JPH09504014A (ja) カルシウムチャネル拮抗薬としてのアミン誘導体類
CA2039102A1 (en) Compounds affecting serotonin receptors
JPS6341390B2 (he)
JP3676110B2 (ja) 新規ベンゾシクロブタン化合物、その製造法及びそれを含有する医薬組成物
JPH0583547B2 (he)
JPH07118249A (ja) 新規フェノキシアルキルピペラジン誘導体

Legal Events

Date Code Title Description
KB Patent renewed
RH Patent void